Vivek Nagaraja, MD, Clinical Assistant Professor and service chief in the Division of Rheumatology, is an active faculty in the Michigan Medicine Scleroderma Program. He currently serves as the Clinical Service Chief for the Division of Rheumatology. He directs the rheumatic disease related interstitial lung disease (RD-ILD) clinics at Michigan Medicine.
Originally from the city of Bangalore in India, Dr. Nagaraja received his medical degree from Ramaiah Medical College. He completed two years of transitional post-doctoral training in the United Kingdom. He subsequently moved to Tucson, Arizona, where he completed a residency in Internal Medicine and fellowship in Geriatric Medicine at the University of Arizona. He then completed a fellowship in Rheumatology at the University of Michigan in 2014. He became a faculty Assistant Professor at the University of Toledo and re-joined the University of Michigan Division of Rheumatology in May 2017 and is an integral part of the Scleroderma program.
Dr. Nagaraja brings a unique geriatric clinical experience of chronic care management into the care of patients with systemic scleroderma and interstitial lung diseases. He is board-certified in Internal Medicine, Geriatric Medicine and Rheumatology, and a member of the American College of Rheumatology. His specific research interests include patient-reported outcomes measurement in rheumatic diseases (including scleroderma) and their implementation in routine clinical care and understanding the unique subset of patients with rheumatic disease who have interstitial lung disease. He is leading clinical trials in systemic scleroderma and interstitial lung diseases at the University of Michigan.